These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12652900)

  • 21. Using the Trail Making test to screen for cognitive impairment in a drug abuse treatment sample.
    Roberts C; Horton AM
    Int J Neurosci; 2001 Aug; 109(3-4):273-80. PubMed ID: 11699333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derived trail making test indices in a sample of alcohol abusers: demographic effects.
    Roberts C; Horton AM
    Int J Neurosci; 2002 Mar; 112(3):337-46. PubMed ID: 12187783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demographic effects on the Trail Making Test in a drug abuse treatment sample.
    Horton AM; Roberts C
    Arch Clin Neuropsychol; 2003 Jan; 18(1):49-56. PubMed ID: 14591477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of the trail making test in the assessment of malingering in a sample of mild traumatic brain injury litigants.
    O'Bryant SE; Hilsabeck RC; Fisher JM; McCaffrey RJ
    Clin Neuropsychol; 2003 Feb; 17(1):69-74. PubMed ID: 12854012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating malingering from genuine cognitive dysfunction using the Trail Making Test-ratio and Stroop Interference scores.
    Egeland J; Langfjaeran T
    Appl Neuropsychol; 2007; 14(2):113-9. PubMed ID: 17523885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demographic characteristics and normative observations for derived-trail making test indices.
    Drane DL; Yuspeh RL; Huthwaite JS; Klingler LK
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Mar; 15(1):39-43. PubMed ID: 11877550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of time and error rates on the trail making test among patients with head injuries, experimental malingerers, patients with suspect effort on testing, and normal controls.
    Ruffolo LF; Guilmette TJ; Willis GW
    Clin Neuropsychol; 2000 May; 14(2):223-30. PubMed ID: 10916197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression-based normative data and equivalent scores for Trail Making Test (TMT): an updated Italian normative study.
    Siciliano M; Chiorri C; Battini V; Sant'Elia V; Altieri M; Trojano L; Santangelo G
    Neurol Sci; 2019 Mar; 40(3):469-477. PubMed ID: 30535956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermanual and alternate-form equivalence on the trail making tests.
    LoSasso GL; Rapport LJ; Axelrod BN; Reeder KP
    J Clin Exp Neuropsychol; 1998 Feb; 20(1):107-10. PubMed ID: 9672824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting exaggeration and malingering with the trail making test.
    Iverson GL; Lange RT; Green P; Franzen MD
    Clin Neuropsychol; 2002 Aug; 16(3):398-406. PubMed ID: 12607151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Children of substance abusers: overview of research findings.
    Johnson JL; Leff M
    Pediatrics; 1999 May; 103(5 Pt 2):1085-99. PubMed ID: 10224196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a WMS-R malingering index in a non-litigating clinical sample.
    Iverson GL; Slick DJ; Franzen MD
    J Clin Exp Neuropsychol; 2000 Apr; 22(2):191-7. PubMed ID: 10779833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Utility of the Trail-Making Test as a Predictor of Driving Performance in Older Adults.
    Papandonatos GD; Ott BR; Davis JD; Barco PP; Carr DB
    J Am Geriatr Soc; 2015 Nov; 63(11):2358-64. PubMed ID: 26503623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of substance abuse on visuographic function.
    Amir T; Bahri T
    Percept Mot Skills; 1994 Feb; 78(1):235-41. PubMed ID: 8177664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairments in adolescent drug-abusers.
    Bernal B; Ardila A; Bateman JR
    Int J Neurosci; 1994 Apr; 75(3-4):203-12. PubMed ID: 8050862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of cognitive functioning in poly-substance abusers.
    Sweeney JA; Meisel L; Walsh VL; Castrovinci D
    J Clin Psychol; 1989 Mar; 45(2):346-51. PubMed ID: 2723094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The trail making test, part B: cognitive flexibility or ability to maintain set?
    Kortte KB; Horner MD; Windham WK
    Appl Neuropsychol; 2002; 9(2):106-9. PubMed ID: 12214820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Trail Making Test.
    Llinàs-Reglà J; Vilalta-Franch J; López-Pousa S; Calvó-Perxas L; Torrents Rodas D; Garre-Olmo J
    Assessment; 2017 Mar; 24(2):183-196. PubMed ID: 26318386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Claims of amnesia for criminal offenses: psychopathology, substance abuse, and malingering.
    Stout RG; Farooque RS
    J Forensic Sci; 2008 Sep; 53(5):1218-22. PubMed ID: 18637867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.